- ￥80
- 富衡生物
- FH-F01
- 国产
- 2025年12月25日
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
99
- 供应商：
上海富衡生物科技有限公司
- 英文名：
Ham's F-12(F12K) Medium
- 规格：
500 mL/瓶
Ham's F-12(F12K)培养基是一款专为原代细胞培养设计的营养培养基，含多种氨基酸、维生素、无机盐及生长因子，适用于肾脏、肝脏等组织细胞的体外培养。本产品采用0.1μm过滤灭菌工艺，确保无菌性及内毒素控制，符合细胞生物学研究标准，支持贴壁/悬浮细胞的高密度增殖培养。
| 产品名称 | Ham's F-12(F12K)培养基 |
|---|---|
| 品牌 | FuHeng |
| 英文名 | Ham's F-12(F12K) Medium |
| 货号 | FH-F01 |
| 规格 | 500 mL/瓶 |
| 特别声明 | 富衡细胞库承诺尽最大努力对实验细胞资源相关信息进行及时更新。但限于当时的技术条件，细胞库资料不保证其准确性。 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验| 论文标题 | DOI | 发表时间 | 期刊 | 影响因子 | 作者列表 |
| Nebulized inhalation of extracellular vesicles containing SPOCK2 suppresses lung adenocarcinoma progression via MAPK inhibition | 10.1007/s12672-025-02626-9 | 2025-05-17 | Discover Oncology | 2.9 | Wang Ying, Liu Ningning, Xu Chuanqin, Wang Jing, Dong Liyang, Yang Shuang, Jiang Junhong |
| Suppression of human and rat 17β-hydroxysteroid dehydrogenase 1 by isothiazolinone-based disinfectants: Insights into mechanism and implications for hormonal homeostasis | 10.1016/j.ecoenv.2025.118248 | 2025-05-05 | ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY | 6.1 | Chuhang Chi, Chaochao Gong, Yunbing Tang, He Zhu, Qian Zhang, Yang Zhu, Shaowei Wang, Ren-shan Ge, Xiaoheng Li |
| Synchronous Sterilization and Immunoreaction Termination for Corneal Transparency Protection in Treating Pseudomonas aeruginosa Induced Bacterial Keratitis | 10.1002/adma.202419209 | 2025-04-01 | ADVANCED MATERIALS | 26.8 | Siyuan Qian, Xuan Wang, Yishun Guo, Wenfang He, Jianhua Yang, Hao Chen, Renlong Li, Lili Su, Xinyi Wang, Yi Shao, Bailiang Wang |
| Benzophenone UV-filters: Inhibition on Human and Rat 17β-hydroxysteroid Dehydrogenase 1 - Insights from 3D-QSAR and Docking Studies | 10.1016/j.jsbmb.2025.106739 | 2025-03-21 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 2.5 | Zhuoqi Chen, Chaochao Gong, Shaowei Wang, Han Lu, Yang Zhu, Ren-shan Ge, Yunbing Tang, Yingfen Ying |
| Baricitinib represses the myocardial fibrosis via blocking JAK/STAT and TGF-β1 pathways in vivo and in vitro | 10.1186/s12872-025-04517-x | 2025-01-31 | BMC Cardiovascular Disorders | 2.3 | Feng Renlei, Liu Hongli, Chen Yunqing |
| Structure-activity relationship and in silico docking analysis of dicarboximide fungicides on 17β-hydroxysteroid dehydrogenase 1 of human, rat, and pig | 10.1016/j.ecoenv.2024.117529 | 2024-12-13 | ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY | 6.2 | Huiqian Chen, Sailing Chen, Yunbing Tang, Yingfen Ying, Shaowei Wang, Yang Zhu, Yiyan Wang, Ren-shan Ge, Ping Duan |
| Inhibitory effects of parabens on human and rat 17β-hydroxysteroid dehydrogenase 1: Mechanisms of action and impact on hormone synthesis | 10.1016/j.tox.2024.153873 | 2024-07-08 | TOXICOLOGY | 4.8 | Zouqi Chen, Chaochao Gong, Yunbing Tang, Yang Zhu, Shaowei Wang, Ren-shan Ge, Yingfen Ying |
| JAK2 inhibitors improve RA combined with pulmonary fibrosis in rats by downregulating SMAD3 phosphorylation | 10.1111/1756-185X.15164 | 2024-05-05 | International Journal of Rheumatic Diseases | 2.4 | Yimei Wei, Dandan Wang, Juan Wu, Jie Zhang |
| Synergistic effect of ca*nabidiol with dasatinib on lung cancer by SRC/PI3K/AKT signal pathway | 10.1016/j.biopha.2024.116445 | 2024-03-18 | BIOMEDICINE & PHARMACOTHERAPY | 6.9 | Qianqian Ye, Changqin Gui, Di Jin, Jiazhen Zhang, Jing Zhang, Na Ma, Li Xu |
| Pirfenidone and nintedanib attenuate pulmonary fibrosis in mice by inhibiting the expression of JAK2 | 10.21037/jtd-23-1057 | 2024-02-26 | Journal of Thoracic Disease | 2.1 | Yan Yang, Xinmeng Wang, Jie Zhang |
| Identifying multi-target drugs for prostate cancer using machine learning-assisted transcriptomic analysis | 10.1080/07391102.2023.2294168 | 2023-12-16 | JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS | 4.4 | Yibin Chang, Hongmei Zhou, Yuxiang Ren, Jiaqi Zhang, Lei Sun, Minghui Du, Jian Zhao, Huiying Chu, Yongshan Zhao |
| Roles of Phonation Types and Decoders' Gender in Recognizing Mandarin Emotional Speech | 10.1044/2023_JSLHR-23-00356 | 2023-11-09 | JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH | 2.6 | Yajie Chang, Xiaoxiang Chen, Fei Chen, Manhong Li |
| Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib | 10.1186/s42358-023-00305-3 | 2023-05-16 | Advances in Rheumatology | 2.3 | Wang Dandan, Wei Yimei, Xu Lulu, Zhang Jie |
| Impediment of Cerebrospinal Fluid Drainage Through Glymphatic System in Glioma | 10.3389/fonc.2021.790821 | 2022-01-10 | Frontiers in Oncology | 5.738 | Xu Dan, Zhou Jie, Mei Hao, Li Huan, Sun Wenbo, Xu Haibo |
| Multifunctional nanoparticle PEG‑Ce6‑Gd for MRI‑guided photodynamic therapy | 10.3892/or.2020.7871 | 2020-11-27 | ONCOLOGY REPORTS | 3.417 | Dan Xu, Aju Baidya, Kai Deng, Yu‑Shuang Li, Bo Wu, Hai‑Bo Xu |
培养某一类型细胞没有固定的培养条件。在MEM中培养的细胞，很可能在DMEM或M199中同样很容易生长。总之，首选MEM做粘附细胞培养、RPMI-1640做悬浮细胞培养，各种目的无血清培养的首选是AIM V培养基（SFM）。在开始进行新的细胞培养时，可以参考下表所列的条件：细胞系 细胞类型 种 组织 推荐使用的培养基293 成纤维细胞 人 胚胎肾 MEM, 10% 热灭活马血清3T6 成纤维细胞 小鼠 胚胎 DMEM, 10% 胎牛血清A549 上皮细胞 人 肺癌 F-12K, 10%胎牛
”。 作为细胞培养的基本营养物质，培养基有几点成功之处值得强调：1.可随细胞系种类的不同自由添加包括血清、激素等在内的补充成分；2.可替代血清；3.根据特殊条件修正培养基。 以下简要介绍培养基的选择： 1.分离和繁殖某种特殊类型的细胞可能需要一种选择性的无血清培养基； 2.为了得到产物所进行的细胞培养则主要依赖于添加血清的Eagle's MEM以及Dulbecco改良的DMEM或者是RPMI1640。 无血清培养基的优点在于：有利于产物的下游处理并可减少外来污染
组织 培养基293 成纤维细胞 人 胚胎肾 MEM, 10% 热灭活马血清IMR-90 成纤维细胞 人 肺 MEM, 10% 胎牛血清 和 NEAAW1-38 成纤维细胞 人 胚胎肺,3月妊娠 MEM, 10% 胎牛血清A549 上皮细胞 人 肺癌 F-12K, 10%胎牛血清A431 上皮型 人 表皮细胞癌 DMEM, 10% 胎牛血清BHL-100 上皮细胞 人 乳房
技术资料暂无技术资料 索取技术资料
